Cedar Mountain Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Cedar Mountain Advisors's NVS Position: Q3 2026 in Review
Cedar Mountain Advisors held its Novartis (NVS) position steady in Q3 2026 at 105 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #365.
Cedar Mountain Advisors first reported a position in NVS in Q4 2019 and has held it in 8 quarters since. The position peaked at $29K in Q4 2019. 1,535 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Cedar Mountain Advisors held 105 shares of Novartis worth $15K as of Q3 2026.
- Cedar Mountain Advisors left its Novartis share count unchanged in Q3 2026.
- Novartis made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #365 holding.
- Cedar Mountain Advisors first reported a position in Novartis in Q4 2019 and has held it in 8 quarters since.
- Cedar Mountain Advisors's Novartis position peaked at $29K in Q4 2019.
- 1,535 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.